Ryan Buchanan

Has grant

University of Southampton

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Uncovering drivers of NAFLD progression using patient derived organoids

Open Date: 2022-10-01

Close Date: 2026-10-01

Grant: Close

HELIXR| Optimising HEpatocellular Cancer surveillance in marginalised patients with Liver cirrhosis via peer support in Wessex – a 12 month pilot

Open Date: 2022-08-01

Close Date: 2024-01-01

Grant: Close

A COMmunity Pharmacy-based intervention to identify people with undiagnosed Alcohol related liver cirrhosis The COMPAC Study

Open Date: 2020-07-01

Close Date: 2022-05-01

Grant: Close

Social network facilitated engagement in people who are Homeless to address InEqualities in alcohol-related Liver Disease - The SHIELD exploratory study

Open Date: 2020-05-01

Close Date: 2022-10-01

Grant: Close

Good Nasal Irrigation and Gargling to Halt Transmission of COvid19 to care-home-based Vulnerable InDividuals – The Good NIGHT COVID pilot cluster randomised control trial

Open Date: 2020-03-01

Close Date: 2020-11-01

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

University of Southampton

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ryan Buchanan

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (15)

Impact of Metabolic Syndrome Traits on Kidney Disease Risk in Individuals with MASLD: A UK Biobank Study

Screening for MASLD in patients with type 2 diabetes: is an early diagnosis a good diagnosis?

Screening to identify people with type 2 diabetes at risk of liver cancer in primary care: a randomised controlled trial protocol

Peer‐Delivered Outreach With Rapid Treatment Pathways for Hepatitis C Testing and Treatment Among Unhoused People

Impact of a community liver pathway on referrals to secondary care liver services: a natural experiment using controlled interrupted time-series analysis

Testing to sustain hepatitis C elimination targets in people who inject drugs: A network‐based model

Correction for length bias reduces the mortality benefit from hepatocellular carcinoma surveillance

Inequity in end‐of‐life care for patients with chronic liver disease in England

The combined effect of alcohol and body mass index on risk of chronic liver disease: A systematic review and meta‐analysis of cohort studies

The testing of people with any risk factor for hepatitis C in community pharmacies is cost‐effective

Reduction of HbA1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?

Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease

Alcohol use disorder and the liver

RE: Early application of haemostatic powder added to standard management for oesophagogastric variceal bleeding: a randomised trial

Prioritising Hepatitis C treatment in people with multiple injecting partners maximises prevention: A real-world network study

Collaborators (9)

Keith Cooper

Salim Khakoo

Dankmar Böhning

THERESA HYDES

Christopher D Byrne

Jennifer Scott

Kate Glyn-Owen

Tina Reinson

Josh Bilson

Make your next move.